Recent IPO GW Pharmaceuticals (GWPH -0.9%) says it's received commercialization approval for its...

|About: GW Pharmaceuticals plc (GWPH)|By:, SA News Editor

Recent IPO GW Pharmaceuticals (GWPH -0.9%) says it's received commercialization approval for its prescription medicine Sativex in Italy. Sativex is a treatment for moderate to severe spasticity in Multiple Sclerosis patients who have not responded adequately to other anti-spasticity medications.